Comments
The Ahmedabad-based Intas Pharmaceuticals Ltd on Tuesday said, it has filed the Draft Red Herring Prospectus with the SEBI for an IPO of its equity shares of face value of Rs 10 each, comprising a fresh issue of shares aggregating up to Rs 425 crore, and an offer for sale of 5.8 million shares by Mozart Ltd.
The issue will be made through a 100 per cent book-building process wherein not more than 50 per cent of the issue will be allocated on a proportionate basis to qualified institutional buyers, 15 per cent to non-institutional bidders and 35 per cent to retail individual bidders, a company release said here.
Kotak Mahindra Capital Company Ltd and Morgan Stanley India Company Private Ltd are the book running lead managers to the issue.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.